These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17427238)

  • 1. Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C.
    Tursi A
    Inflamm Bowel Dis; 2007 Sep; 13(9):1189-90. PubMed ID: 17427238
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
    Sprenger R; Sagmeister M; Offner F
    Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
    [No Abstract]   [Full Text] [Related]  

  • 3. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D; Kuchler E; Deming P; Arora S
    Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin.
    Watanabe T; Inoue M; Harada K; Homma N; Uchida M; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
    Gut; 2006 Nov; 55(11):1682-3. PubMed ID: 17047132
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin for chronic hepatitis C].
    Watanabe T; Inoue M; Harada K; Homma N; Uchida M; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
    Nihon Shokakibyo Gakkai Zasshi; 2006 Sep; 103(9):1061-6. PubMed ID: 16953104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pouchitis with combination therapy with peg-interferon alpha-2b and ribavirin for chronic hepatitis C in a patient with ulcerative colitis who underwent pouch surgery.
    Morimoto K; Yamagami H; Hosomi S; Ohira M; Suekane T; Kamata N; Sogawa M; Watanabe K; Tominaga K; Watanabe T; Fujiwara Y; Tamori A; Oshitani N; Arakawa T
    Am J Gastroenterol; 2009 Jun; 104(6):1609-10. PubMed ID: 19491886
    [No Abstract]   [Full Text] [Related]  

  • 7. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
    Ku JY; Sharma A
    Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis of inflammatory bowel disease in chronic hepatitis C patients treated with pegylated interferon and ribavirin: coincidence or consequence?
    Salgueiro P; Lago P; Pedroto I
    J Crohns Colitis; 2013 Jun; 7(5):e194. PubMed ID: 23219260
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythema Annulare Centrifugum in the Era of Triple Therapy With Boceprevir Plus Pegylated Interferon α-2b and Ribavirin for Hepatitis C Virus Infection.
    di Meo N; Stinco G; Fadel M; Errichetti E; Trevisan G
    J Cutan Med Surg; 2015; 19(3):203-4. PubMed ID: 26060126
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis C therapy is not pleasant. Patients must be prepared!].
    MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619237
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
    Paraná R; Schinoni MI; de Freitas LA; Codes L; Cruz M; Andrade Z; Trepo C
    Liver Int; 2006 Nov; 26(9):1148-54. PubMed ID: 17032416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation.
    Manz M; Steuerwald M
    Transpl Infect Dis; 2007 Mar; 9(1):60-1. PubMed ID: 17313476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peginterferon- and ribavirin-induced bipolar episode successfully treated with lamotrigine without discontinuation of antiviral therapy.
    Navinés R; Castellví P; Solà R; Martín-Santos R
    Gen Hosp Psychiatry; 2008; 30(4):387-9. PubMed ID: 18585548
    [No Abstract]   [Full Text] [Related]  

  • 14. Co-infections. German doctors treat hepatitis C early, with some success.
    TreatmentUpdate; 2006; 18(5):3-4. PubMed ID: 17209229
    [No Abstract]   [Full Text] [Related]  

  • 15. Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon α-2b and ribavirin in a patient with hepatitis C.
    Colomba C; Rubino R; Siracusa L; Mazzola G; Titone L
    J Antimicrob Chemother; 2012 Jan; 67(1):249-50. PubMed ID: 21965434
    [No Abstract]   [Full Text] [Related]  

  • 16. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.
    Kontorinis N; Agarwal K; Elhajj N; Fiel MI; Schiano TD
    Liver Transpl; 2006 May; 12(5):827-30. PubMed ID: 16628699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

  • 18. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N; Aykin N; Demirdal T; Cevik F
    Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
    [No Abstract]   [Full Text] [Related]  

  • 19. Pernicious anemia during peginterferon-alpha2b plus ribavirin therapy for chronic hepatitis C.
    Musialik J; Petelenz M; Błoñska-Fajfrowska B; Hartleb M
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):593-4. PubMed ID: 19194303
    [No Abstract]   [Full Text] [Related]  

  • 20. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin.
    Bongiovanni M; Ranieri R; Ferrero S; Casanova F; Monforte Ad
    AIDS; 2006 Oct; 20(15):1989-90. PubMed ID: 16988527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.